Eprotirome
| Title | Journal |
|---|---|
| Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia. | Bioorganic & medicinal chemistry 20120601 |
| Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia. | Core evidence 20120101 |
| Familial hypercholesterolemia: present and future management. | Current cardiology reports 20111201 |
| Lipoprotein(a): medical treatment options for an elusive molecule. | Current pharmaceutical design 20110101 |
| Association between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humans. | PloS one 20110101 |
| Lipid lowering with thyroid hormone and thyromimetics. | Current opinion in lipidology 20101201 |
| Lipoprotein(a) as a cardiovascular risk factor: current status. | European heart journal 20101201 |
| Thyroid hormones, mitochondrial bioenergetics and lipid handling. | Current opinion in endocrinology, diabetes, and obesity 20101001 |
| Thyroid hormone receptor and lipid regulation. | Current opinion in investigational drugs (London, England : 2000) 20101001 |
| Lipids: Eprotirome shows promise as a novel way to target dyslipidemia. | Nature reviews. Endocrinology 20100701 |
| Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. | Lancet (London, England) 20100508 |
| Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. | The New England journal of medicine 20100311 |
| Recent advances in preventing cardiovascular disorders by managing lipid levels. | F1000 medicine reports 20100101 |
| The resurgence of thyromimetics as lipid-modifying agents. | Current opinion in investigational drugs (London, England : 2000) 20090901 |
| Hotline sessions presented at the American College of Cardiology Congress 2009. | Clinical research in cardiology : official journal of the German Cardiac Society 20090601 |
| [Thyroid hormone analogs: an important biological supply and new therapeutic possibilities]. | Annales d'endocrinologie 20080901 |
| Selective thyromimetics for atherosclerosis and dyslipidaemia: another old target making progress. | Expert opinion on investigational drugs 20080501 |